161 related articles for article (PubMed ID: 425078)
1. Assay of total factor XII and of activated factor XII in plasma with a chromogenic substrate.
Vinazzer H
Thromb Res; 1979 Jan; 14(1):155-66. PubMed ID: 425078
[No Abstract] [Full Text] [Related]
2. Coagulation activity of surface activated plasma in vivo.
Swedenborg J; Kourias E; Olsson P
Thromb Res; 1979; 16(1-2):231-7. PubMed ID: 505418
[No Abstract] [Full Text] [Related]
3. Contributions of human platelets to the proteolytic activation of blood coagulation factors XII and XI.
Walsh PN; Griffin JH
Blood; 1981 Jan; 57(1):106-18. PubMed ID: 7004531
[No Abstract] [Full Text] [Related]
4. Cofactor of the "lupus anticoagulant".
Rivard GE; Schiffman S; Rapaport SI
Thromb Diath Haemorrh; 1974 Dec; 32(2-3):554-63. PubMed ID: 4141516
[No Abstract] [Full Text] [Related]
5. The procoagulant activity of granulocytes.
Saba HI; Herion JC; Walker RI; Roberts HR
Proc Soc Exp Biol Med; 1973 Feb; 142(2):614-20. PubMed ID: 4689394
[No Abstract] [Full Text] [Related]
6. [On the coagulation factors from V through XIII].
Yoshida K; Tagawa N
Nihon Rinsho; 1973 Apr; 31(4):755-64. PubMed ID: 4580392
[No Abstract] [Full Text] [Related]
7. Transfusion support for congenital clotting deficiencies other than haemophilia.
Lewis JH; Spero JA; Ragni MV; Bontempo FA
Clin Haematol; 1984 Feb; 13(1):119-35. PubMed ID: 6609789
[No Abstract] [Full Text] [Related]
8. Laboratory diagnosis of congenital coagulation defects.
Lowe GD; Forbes CD
Clin Haematol; 1979 Feb; 8(1):79-94. PubMed ID: 310747
[No Abstract] [Full Text] [Related]
9. Assessment of Actin FS and Actin FSL sensitivity to specific clotting factor deficiencies.
Lawrie AS; Kitchen S; Purdy G; Mackie IJ; Preston FE; Machin SJ
Clin Lab Haematol; 1998 Jun; 20(3):179-86. PubMed ID: 9681235
[TBL] [Abstract][Full Text] [Related]
10. Thrombosis or myocardial infarction in congenital clotting factor abnormalities and chronic thrombocytopenias: a report of 21 patients and a review of 50 previously reported cases.
Goodnough LT; Saito H; Ratnoff OD
Medicine (Baltimore); 1983 Jul; 62(4):248-55. PubMed ID: 6348471
[TBL] [Abstract][Full Text] [Related]
11. Contact factors in health and disease.
Saito H
Semin Thromb Hemost; 1987 Jan; 13(1):36-49. PubMed ID: 3551076
[No Abstract] [Full Text] [Related]
12. Reduction of salivary tissue factor (thromboplastin) activity by warfarin therapy.
Zacharski LR; Rosenstein R
Blood; 1979 Mar; 53(3):366-74. PubMed ID: 760859
[TBL] [Abstract][Full Text] [Related]
13. [Determination of factor XII and plasma prekallikrein with chromozym PK].
Stürzebecher J; Klessen C; Markwardt F
Z Med Lab Diagn; 1982 Oct; 23(5):306-11. PubMed ID: 6924817
[No Abstract] [Full Text] [Related]
14. Prothrombin utilization in congenital coagulation deficiency states.
Owen CA; Thompson JH
Thromb Diath Haemorrh; 1971 Jun; 25(2):297-311. PubMed ID: 5568049
[No Abstract] [Full Text] [Related]
15. Activation of factor VII during alimentary lipemia occurs in healthy adults and patients with congenital factor XII or factor XI deficiency, but not in patients with factor IX deficiency.
Miller GJ; Martin JC; Mitropoulos KA; Esnouf MP; Cooper JA; Morrissey JH; Howarth DJ; Tuddenham EG
Blood; 1996 May; 87(10):4187-96. PubMed ID: 8639777
[TBL] [Abstract][Full Text] [Related]
16. [Blood coagulation disorders caused by abnormal blood coagulation factors].
Fiedler H
Z Arztl Fortbild (Jena); 1972 Jul; 66(13):692-8. PubMed ID: 4636972
[No Abstract] [Full Text] [Related]
17. Hageman-factor-dependent fibrinolysis: generation of fibrinolytic activity by the interaction of human activated factor XI and plasminogen.
Mandle RJ; Kaplan AP
Blood; 1979 Oct; 54(4):850-62. PubMed ID: 89876
[TBL] [Abstract][Full Text] [Related]
18. The role of HF cofactor in the Hageman factor-dependent fibrinolytic mechanism.
Iatridis PG; Gadarowski JJ; Iatridis SG
Acta Haematol; 1981; 66(4):257-63. PubMed ID: 6800192
[TBL] [Abstract][Full Text] [Related]
19. The effect of chronic administration of lathyrogen (beta-aminopropionitrile) on blood clotting and fibrinolytic system in rabbits.
Bańkowski E; Worowski K
Thromb Diath Haemorrh; 1969 Nov; 22(2):372-6. PubMed ID: 5380956
[No Abstract] [Full Text] [Related]
20. Reduced tissue factor (thromboplastin) activity in von Willebrand's disease.
Zacharski LR; Rosenstein R; Cornwell GG; Davis WM; McIntyre OR
Am J Med; 1974 Jul; 57(1):102-7. PubMed ID: 4546024
[No Abstract] [Full Text] [Related]
[Next] [New Search]
